课题基金 / 基金详情

Development of a new topical treatment system for the eye

Development of a new topical treatment system for the eye
开发新型眼部局部治疗系统
批准号:
17591834
负责人:
OHGURO Nobuyuki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

OHGURO Nobuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We evaluated chitosan-coated lipid nanosphere (CS-LNS) as a new topical eye drop system which can target the posterior pole of the eye. First, we did topical treatment on eyes of albino rabbit with CS-LNS containing DiI dye. CS-non-coated LNS was served as control. 1 hour after eye drops, eyes were enucleated and accumulation of DiI was examined by confocal laser scanning microscopy. DiI significantly accumulated in conjunctiva, cornea and anterior sclera-choroid-retina, but less in posterior sclera-choroid-retina. Next, we used CS-LNS containing cyclosporine as a topical treatment on eyes of albino rabbit. 1 hour after eye drops, eyes were enucleated and concentration of cyclosporine in following parts of the eyes, conjunctiva, cornea, iris, aqueous humor, lens vitreous, anterior sclera-choroid-retina and posterior sclera-choroid-retina, was measured by HPLC. We found significant levels of cyclosporine in conjunctiva and cornea. In anterior sclera-choroid-retina, the concentration of … More the drug was relatively lower than that of in conjunctiva and cornea. In posterior segment of the eye, it was much less. In iris, aqueous humor, lens and vitreous, we could not detect cyclosporine. These results suggested that drug delivery pathway with using CS-LNS was from conjunctiva to sclera via tenon. Pathway through cornea might not be a main road. Our study demonstrated that CS-LNS can be a new topical delivery system targeting to the posterior segment of the eye.To search a new targeting molecule for the treatment of intraocular inflammation, we investigated changes in gene expression of cytokines and chemokines and their receptors after systemic prednisolone treatment in experimental autoimmune uveoretinitis (EAU). Gene expression analysis was conducted with the cDNA microarray, which contains 117 individual transcripts encoding the genes of the cytokines and chemokines and their receptors (29 cytokines/34 cytokine receptors; 33 chemokines/21 chemokine receptors). Comparisons of expression between predonisolone-treated and placebo-treated EAU mice at each time point were performed. The genes were sorted into clusters based on expression profiles to clarify the gene regulation pattern after treatment. Hierarchical cluster analysis of the microarray demonstrated that gene expression changes in EAU after treatment showed four patterns: flat, mountain, large downhill, and small downhill. These findings may open a new avenue to identify new therapeutic targets in ocular inflammation. Less
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Micro Serial, Analysis of Gene Expression in Normal Human Choroid and Retinal Pigment Epithelial Transcriptomes.
微系列,正常人脉络膜和视网膜色素上皮转录组中基因表达的分析。
DOI: --
发表时间: 2005
期刊: Japanese Journal of Ophthalmology 49・1
影响因子: --
作者: [Kobashi-Hashida, M.]
通讯作者: M.
DOI: --
发表时间: 2005
期刊: Jpn J Ophthalmol 49
影响因子: --
作者: [Oishi M, Maeda S, Nakamura A, Kurokawa N, Ohguro N, Tano Y]
通讯作者: Tano Y
DOI: --
发表时间: 2006
期刊: Am J Ophthalmol. 141
影响因子: --
作者: [Ohguro N, Yamanaka E, Otori Y, Saishinn Y, Tano Y]
通讯作者: Tano Y
Intraocular Concentration of Intravenous Prednisolone in Experimental Autoimmune Uveoretinitis Mice.
实验性自身免疫性葡萄膜视网膜炎小鼠静脉注射泼尼松龙的眼内浓度。
DOI: --
发表时间: 2006
期刊: Jpn J ophthalmol. 50
影响因子: --
作者: [Hashida N, Ohguro N, Arakawa Y, Kurokawa N, Tano Y]
通讯作者: Tano Y
7
    Application of sialyl-Lewis X conjugated liposome to the murine experimental autoimmune uveoretinitis
    • 批准号:
      15591852
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      OHGURO Nobuyuki
    • 依托单位:
    Characterization of the p130cas pathway in Ocular Cell Adhesions
    • 批准号:
      12671707
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      2000
    • 负责人:
      OHGURO Nobuyuki
    • 依托单位:
    国内基金
    海外基金
    Ti3C2@Chitosan-MnFe2O4改良型胆管支架经PTT/CDT协同作用治疗胆道恶性梗阻的应用研究
    • 批准号:
      82303708
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      熊文芳
    • 依托单位:
    基于鲍曼不动杆菌纳米疫苗Chitosan-PLGA-rOmp22粘膜免疫效应的机制研究
    • 批准号:
      82100014
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      杜兴冉
    • 依托单位:
    基于微流控芯片技术构建PLGA/Chitosan复合载药神经导管及在周围神经损伤修复中的应用研究
    • 批准号:
      81901251
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.5万元
    • 批准年份:
      2019
    • 负责人:
      李明
    • 依托单位:
    Chitosan修饰的低氧激活型光敏脂质体在三阴乳腺癌治疗中的实验研究
    • 批准号:
      81602728
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      17.0万元
    • 批准年份:
      2016
    • 负责人:
      杨蕊
    • 依托单位: